Clinical trial
An Investigator Initiated and Conducted, Prospective, Multicentre, Randomised Outcome-blinded Pilot Study of Antiplatelet Therapy in Patients with a History of Stroke Due to Intracerebral Haemorrhage
NCT04522102 is registered in ClinicalTrials.gov with The George Institute for Global Health, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Investigator Initiated and Conducted, Prospective, Multicentre, Randomised Outcome-blinded Pilot Study of Antiplatelet Therapy in Patients with a History of Stroke Due to Intracerebral Haemorrhage
- Lead sponsor
- The George Institute for Global Health, China
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 3, 2021
- Completion date
- October 13, 2023
- Enrollment
- 80 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
intracerebral hemorrhage